Meeting to be held in London on October 8-9 hosted by Piper Sandler.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- Positive Outlook on BridgeBio Pharma Driven by Promising Pipeline and Strategic Initiatives
- BridgeBio presented data from ATTRibute-CM study on acoramidis
- BridgeBio participates in a conference call with Piper Sandler
- Positive Buy Rating for BridgeBio Pharma’s Encaleret Driven by Promising Phase 2 Results and Significant Market Potential
- BridgeBio price target raised to $82 from $72 at UBS